Search

9 May 2022: Hybridoma cell line producing YTH 89.1 antibodies raised against human CD235a which are rat monoclonal antibodies of the IgG2b isotype.

27 Sep 2022: Cambridge’s leadership in knowledge exchange has been recognised in today's Knowledge Exchange Framework 2 (KEF2) results, published by Research England.

9 May 2022: CHO cells transfected to express human FcgRlla allotype 131R as a transmembrane protein with its native intracellular domain.

11 Apr 2022: Our consultancy services team supported Department of Chemical Engineering and Biotechnology researchers in testing anti-viral materials.

9 May 2022: CHO cells transfected to express human FcgRlla allotype 131H as a transmembrane protein with its native intracellular domain.

8 Nov 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. 7 November 2022. Cambridge spin-out raises £4.2m to tackle gigatonnes of emissions from highly pollutive cement industry. Share:. University of Cambridge and UCL joint spin-out to

9 May 2022: Questionnaire developed at the University of Cambridge and validated for use with reception- and nursery-aged children.

11 Apr 2022: Cambridge Enterprise is collaborating with 3C Programme, an international consortium supporting the development of technology innovation ecosystems in Argentina.

9 May 2022: Hybridoma cell line producing YTH 71.3 antibodies raised against human CD66acd which are rat monoclonal antibodies of the IgG2a isotype.

11 Apr 2022: Centessa Pharmaceuticals, which launched with $250 million in Series A financing, acquired three Cambridge Enterprise portfolio companies.

12 Apr 2022: University of Cambridge spin-out RegGenome announces the completion of a $6 million seed funding round.

9 May 2022: CHO cells transfected to express human FcgRllb allotype 131R as a transmembrane protein with its native intracellular domain.

9 May 2022: Hybridoma cell line producing YTH 80.103 antibodies raised against human CD45R which are rat monoclonal antibodies of the IgG2b isotype.

11 Apr 2022: Mining millions of words in news articles, business reports, and social media posts, Versed AI’s technology maps out multi-tier supply chains, revealing patterns and shining light on missing links.

8 Dec 2022: Today’s news, last night’s event, and the subsequent number of signatures we have secured for the charter to date, have confirmed that we are securing visible commitment from all

9 May 2022: Hybridoma cell line producing YTH 906.9HL antibodies raised against human CD25 which are rat monoclonal antibodies of the IgG2b isotype.

9 May 2022: Hybridoma cell line producing YW 62.3.20 antibodies raised against mouse CD45 which are rat monoclonal antibodies of the IgG2b isotype.

8 Mar 2022: Cambridge spin-out DIOSynVax will receive $42 million to develop a vaccine candidate to protect against existing and future variants of SARS-CoV-2.

9 May 2022: Hybridoma cell line producing YTA 74.4.4 antibodies raised against mouse CD71 which are monoclonal antibodies of the IgG2a isotype.

8 Mar 2022: Cambridge Enterprise joins £2.2 million seed round for construction data company BKwai, helping develop smarter, more sustainable infrastructure.

9 May 2022: Hybridoma cell line against rat IgG2b, producing NORIg 7.16.2 antibodies which are mouse monoclonal antibodies.

9 May 2022: Hybridoma cell line producing YTS 213.1.1 antibodies raised against mouse CD18 which are rat monoclonal antibodies of the IgG2a isotype.

31 May 2022: Cambridge Enterprise joins H&M in an £18 million Series B investment round for portfolio company Colorifix

9 May 2022: KARPAS 1718 Human Splenic Lymphoma cell line useful in oncology research, developed at the University of Cambridge.

9 May 2022: CHO cells transfected to express human FcgRIIIa of the 158F allotype on their surface as glycosyl-phosphatidylinositol-anchored molecules.

9 May 2022: CHO cells transfected to express human FcgRIIIa of the 158V allotype on their surface as glycosyl-phosphatidylinositol-anchored molecules.

9 May 2022: KARPAS 45 Human T-cell Leukemia cell line useful in oncology research, developed at the University of Cambridge.

9 May 2022: KARPAS 353 Human B-cell Leukaemia cell line useful in oncology research, developed at the University of Cambridge.

9 May 2022: JBIG-KIT software library is an implementation of the JBIG1 data compression standard (ITU-T T.82), which was designed for bi-level high-resolution image data.

9 May 2022: KARPAS 231 Human B-cell Leukaemia cell line useful in oncology research, developed at the University of Cambridge.

9 May 2022: Hybridoma cell line producing YBM 29.2.1antibodies raised against mouse Thy-1, which are rat monoclonal antibodies of the IgG2c isotype.

9 May 2022: Sharp graphite tips have been developed in the lab of Dr Amalio Fernandez-Pacheco at the University of Cambridge using a three-step polishing method.

9 May 2022: Tetrabutylammonium (4'methyl-[2,2'bipyridin]-5yl)methanesulfonate is a ligand for iridium to control regioselectivity of iridium-catalysed borylation

9 May 2022: Hybridoma cell line producing SIg 375 antibodies raised against sheep immunoglobulin G which are mouse monoclonal antibodies of the IgG isotype.

9 May 2022: Hybridoma cell line producing SIg 482 antibodies raised against sheep immunoglobulin G which are mouse monoclonal antibodies of the IgG isotype.

9 May 2022: Hybridoma cell line producing SIg 743 antibodies raised against sheep immunoglobulin G which are mouse monoclonal antibodies of the IgG isotype.

9 May 2022: KARPAS 620 Human Plasma Cell Leukemia cell line useful in oncology research, developed at the University of Cambridge.

9 May 2022: Hybridoma cell line producing YTH 862.2 antibodies raised against human HLA-class I which are rat monoclonal antibodies of the IgG2b isotype.

9 May 2022: Hybridoma cell line producing IR CT-1 antibodies against the C-terminal portion of the human insulin receptor beta subunit, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR 83-7 antibodies raised against the human insulin receptor, which are mouse monoclonal antibodies of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR CT-3 antibodies against the C-terminal portion of the human insulin receptor beta subunit, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR 47-9 antibodies raised against the alpha subunit of the human insulin receptor,which are monoclonals of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR 18-45 antibodies against the beta subunit N-terminal region of the human insulin receptor, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR 18-43 antibodies against the beta subunit N-terminal region of the human insulin receptor, which are of the IgG2a isotype.

9 May 2022: Hybridoma cell line producing IR 18-42 antibodies against the beta subunit N-terminal region of the human insulin receptor, which are of the IgG2b isotype.

9 May 2022: Hybridoma cell line producing IR 83-14 antibodies against the alpha subunit of the human insulin receptor, which are mouse monoclonals of the IgG2a isotype.

9 May 2022: Hybridoma cell line producing YTS 154.7.7.10 antibodies raised against mouse Thy-1 which are rat monoclonal antibodies of the IgG2b isotype.

9 May 2022: Hybridoma cell line producing IR 83-12 antibodies raised against the extracellular domain of the human insulin receptor, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR 18-44 antibodies raised against beta subunit of the human insulin receptor which are mouse monoclonals of IgG2b isotype.

9 May 2022: Hybridoma cell line producing IR 25-49 antibodies raised against the alpha subunit of the human insulin receptor, which are of the IgG1 isotype.